BrightSpring Health Services, Inc. (BTSG)
NASDAQ:BTSG
Want to see BTSG full AI Analyst Report?
Earnings Data
Report Date
Jul 31, 2026Before Open (Confirmed)
Period Ending
2026 (Q2)Consensus EPS Forecast
0.39Last Year’s EPS
0.22Same Quarter Last Year
Strong Buy
Based on 14 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The call presented strong operational and financial momentum: double-digit revenue growth, a 45% increase in adjusted EBITDA, improved margins, solid segment performance in specialty, infusion and home health, successful integration contributions, and a meaningful cash proceeds event to strengthen the balance sheet. These positives are tempered by clear, quantified headwinds from IRA impacts and brand-to-generic conversions (~$600M aggregate headwind referenced), a Q1 rise in corporate investments, and ongoing PBM/payer competitive dynamics. Management characterized the headwinds as expected and actionable and reiterated guidance, suggesting confidence in execution and mitigation plans.Company Guidance
Strong Top-Line Growth
Total company revenue of $3.6 billion in Q1 2026, up 26% year-over-year. Pharmacy Solutions revenue $3.2 billion (+25% YoY) and Provider Services revenue $442 million (+28% YoY).
Robust Profitability and Margin Expansion
Adjusted EBITDA of $190 million in Q1, up 45% year-over-year, with an adjusted EBITDA margin of 5.3% (improvement of ~70 basis points YoY). Adjusted EPS of $0.39.
Pharmacy Specialty & Infusion Momentum
Specialty & Infusion revenue of $2.6 billion (+36% YoY). Specialty & Infusion scripts grew ~30% YoY (specialty higher; infusion mid‑teens). Pharmacy Solutions gross profit $301 million (+48% YoY) and adjusted EBITDA $169 million (+46% YoY). Key operating metrics: medication possession ratio 92.1% and time-to-first-fill 4.6 days.
Provider Services Strength and Successful Integrations
Provider Services gross profit $181 million (+35% YoY) and adjusted EBITDA $66 million (+29% YoY) with a 14.9% adjusted EBITDA margin (up ~10 bps). Home Health revenue $266 million (+49% YoY); acquired Amedisys and LHC branches contributed ~$79 million of revenue and ~$9 million of adjusted EBITDA in Q1, with management expecting ~ $30 million of EBITDA contribution in year 1 from integration.
Operational and Quality Excellence
High quality metrics across services: Home Health >91% of branches are 4+ stars; timely initiation of care >99%; 65 Home Health locations named Best Home Health. Infusion patient satisfaction 94%; 97% of discharges due to therapy completion. Home & Community dispensing accuracy 99.99%, order completeness 99%, on-time delivery 96%.
Cash Generation and Balance Sheet Improvement
Operating cash flow of $123 million in Q1 (excluding Community Living fees). Completed sale of Community Living for ~$835M gross ($811M net proceeds before tax) to be used for debt paydown and liquidity. Net debt ~ $1.7 billion and leverage improved to 2.27x (from 2.99x at year-end 2025); pro forma leverage ~2.40x when factoring expected Q2 taxes.
2026 Guidance and Forward Outlook
Full-year 2026 revenue guidance $14.725B–$15.225B (≈14.1%–17.9% growth ex-Community Living) and total adjusted EBITDA guidance $795M–$825M (≈28.7%–33.6% growth ex-Community Living). Company expects ~ $500M of annual operating cash flow (ex-Community Living).
BrightSpring Health Services, Inc. (BTSG) Earnings, Revenues Date & History
BTSG Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
BTSG Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 01, 2026 | $47.97 | $52.58 | +9.61% |
Feb 27, 2026 | $40.13 | $41.43 | +3.24% |
Oct 28, 2025 | $34.00 | $34.05 | +0.15% |
Aug 01, 2025 | $20.65 | $19.64 | -4.89% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does BrightSpring Health Services, Inc. (BTSG) report earnings?
BrightSpring Health Services, Inc. (BTSG) is schdueled to report earning on Jul 31, 2026, Before Open (Confirmed).
What is BrightSpring Health Services, Inc. (BTSG) earnings time?
BrightSpring Health Services, Inc. (BTSG) earnings time is at Jul 31, 2026, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is BTSG EPS forecast?
BTSG EPS forecast for the fiscal quarter 2026 (Q2) is 0.39.